What is the latest Cipla Limited news?

Get real-time updates on Cipla Limited stock news with Alerfo's instant alert system. Stay informed about market movements and company announcements like earnings, split, and dividends.

How does market news affect Cipla Limited share price?

News impacts CIPLA based on market sentiment. Positive news typically drives prices up, while negative news can cause declines. Alerfo's engine analyzes sentiment in real-time for institutional-grade accuracy.

Where can I get real-time Cipla Limited alerts?

Alerfo provides real-time alerts for Cipla Limited news via WhatsApp and Web. Set up custom alerts based on symbols you own to never miss a critical market shift.

What is Cipla Limited's current market performance?

Cipla Limited currently operates in the Healthcare sector with an emphasis on Intelligence. You can track its live LTP (Last Traded Price), Volume, and high/low metrics on our dedicated intelligence page.

Cipla Limited Latest News Today (2026)

Market Fundamentals

Market Cap

₹108,578 Cr

P/E Ratio

N/A

Dividend Yield

0.00%

52W High

₹N/A

Stock Intelligence & News

The Hindu Business Line Markets•2026-09-04

Cipla slips after Qilu Pembrolizumab deal; Morgan Stanley flags crowded field

Cipla stock trades at ₹1,388, down 0.48% or ₹6.70 from its previous close of ₹1,394.70

Read Full Analysis →

BSE Announcements•2026-09-02

Cipla Ltd (500087)

Please find attached newspaper publication regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares

Read Full Analysis →

NSE Online Announcements•2026-08-31

Cipla Limited

Cipla Limited has informed the Exchange regarding a press release dated August 31, 2026, titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)". |SUBJECT: Press Release

Read Full Analysis →

NDTV Profit - latest•2026-08-29

Cipla Pharma License Cancellation: FDA Withdraws Order After HC Raps It For Going "Overboard"

Bombay High Court Pulls Up FDA Over Cipla License Cancellation

Read Full Analysis →

NDTV Profit - latest•2026-08-28

FDA Crackdown: Cipla Arm Loses Pune Drug Sales Licence For Storage Deficiencies, Illegal Ads

The cancellation took effect from August 27, according to the Maharashtra FDA's action against the company's Pune operations.

Read Full Analysis →

BSE Announcements•2026-08-27

Cipla Ltd (500087)

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / Institutional Investor Meeting with the Company.

Read Full Analysis →

BSE Announcements•2026-08-25